Overview
Safety and Efficacy of Twelve Hours Duration of MgSO4 in the Treatment of Eclampsia in Low Resource Setting in Sudan
Status:
Unknown status
Unknown status
Trial end date:
2019-06-30
2019-06-30
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
the investigators assume that magnesium sulphate for treating eclampsia can be safely reduced from 24 hours to shorter duration of therapeutic anticonvulsant effect for 12 hours. Short duration of drug exposure is suitable for low resource setting where there is little tools or busy staff for monitoring drug toxicity.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Gadarif UniversityTreatments:
Magnesium Sulfate
Criteria
Inclusion Criteria:- clinical diagnosis of eclampsia
- must accept to participate in the study
Exclusion Criteria:
- epilepsy